160 related articles for article (PubMed ID: 33911808)
1.
Park HS; Kim JH; Cho MY; Chung KY; Roh MR
Ann Dermatol; 2021 Feb; 33(1):18-25. PubMed ID: 33911808
[TBL] [Abstract][Full Text] [Related]
2. KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
Zebary A; Omholt K; Vassilaki I; Höiom V; Lindén D; Viberg L; Kanter-Lewensohn L; Johansson CH; Hansson J
J Dermatol Sci; 2013 Dec; 72(3):284-9. PubMed ID: 23993026
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients.
Roh MR; Park KH; Chung KY; Shin SJ; Rha SY; Tsao H
Am J Cancer Res; 2017; 7(1):134-138. PubMed ID: 28123854
[TBL] [Abstract][Full Text] [Related]
4. Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
Roh MR; Gupta S; Park KH; Chung KY; Lauss M; Flaherty KT; Jönsson G; Rha SY; Tsao H
J Invest Dermatol; 2016 May; 136(5):1002-1011. PubMed ID: 26854490
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).
Elefanti L; Zamuner C; Del Fiore P; Stagni C; Pellegrini S; Dall'Olmo L; Fabozzi A; Senetta R; Ribero S; Salmaso R; Mocellin S; Bassetto F; Cavallin F; Tosi AL; Galuppini F; Dei Tos AP; Menin C; Cappellesso R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917086
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.
Vazquez Vde L; Vicente AL; Carloni A; Berardinelli G; Soares P; Scapulatempo C; Martinho O; Reis RM
Melanoma Res; 2016 Apr; 26(2):93-9. PubMed ID: 26709572
[TBL] [Abstract][Full Text] [Related]
7. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
Moon KR; Choi YD; Kim JM; Jin S; Shin MH; Shim HJ; Lee JB; Yun SJ
J Invest Dermatol; 2018 Apr; 138(4):933-945. PubMed ID: 29191620
[TBL] [Abstract][Full Text] [Related]
8.
Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
[No Abstract] [Full Text] [Related]
9. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
Goel VK; Lazar AJ; Warneke CL; Redston MS; Haluska FG
J Invest Dermatol; 2006 Jan; 126(1):154-60. PubMed ID: 16417231
[TBL] [Abstract][Full Text] [Related]
10. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
[TBL] [Abstract][Full Text] [Related]
11. Frequent Occurrence of
Jansen P; Cosgarea I; Murali R; Möller I; Sucker A; Franklin C; Paschen A; Zaremba A; Brinker TJ; Stoffels I; Schadendorf D; Klode J; Hadaschik E; Griewank KG
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30995742
[TBL] [Abstract][Full Text] [Related]
12. Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients.
Ofner R; Ritter C; Heidenreich B; Kumar R; Ugurel S; Schrama D; Becker JC
J Cancer Res Clin Oncol; 2017 Apr; 143(4):613-617. PubMed ID: 27990595
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas.
Holman BN; Van Gulick RJ; Amato CM; MacBeth ML; Davies KD; Aisner DL; Robinson WA; Couts KL
Melanoma Res; 2020 Dec; 30(6):562-573. PubMed ID: 33156595
[TBL] [Abstract][Full Text] [Related]
14. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
[TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutation is uncommon in acral lentiginous melanoma.
Liau JY; Tsai JH; Jeng YM; Chu CY; Kuo KT; Liang CW
J Cutan Pathol; 2014 Jun; 41(6):504-8. PubMed ID: 24588324
[TBL] [Abstract][Full Text] [Related]
16. Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients.
Manrique-Silva E; Rachakonda S; Millán-Esteban D; García-Casado Z; Requena C; Través V; Kumar R; Nagore E
Br J Dermatol; 2021 Mar; 184(3):504-513. PubMed ID: 32506424
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic analysis of melanomas arising in acral sites.
Zaremba A; Murali R; Jansen P; Möller I; Sucker A; Paschen A; Zimmer L; Livingstone E; Brinker TJ; Hadaschik E; Franklin C; Roesch A; Ugurel S; Schadendorf D; Griewank KG; Cosgarea I
Eur J Cancer; 2019 Sep; 119():66-76. PubMed ID: 31419753
[TBL] [Abstract][Full Text] [Related]
18.
Ren M; Zhang J; Kong Y; Bai Q; Qi P; Zhang L; Wang Q; Zhou X; Chen Y; Zhu X
Ann Transl Med; 2022 Jan; 10(2):31. PubMed ID: 35282092
[TBL] [Abstract][Full Text] [Related]
19. Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?
Paolino G; Bekkenk MW; Didona D; Eibenschutz L; Richetta AG; Cantisani C; Viti G; Carbone A; Buccini P; De Simone P; Ferrari A; Scali E; Calvieri S; Silipo V; Cigna E; Viti GP; Bottoni U
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):842-8. PubMed ID: 27010139
[TBL] [Abstract][Full Text] [Related]
20. GAB2 amplifications refine molecular classification of melanoma.
Chernoff KA; Bordone L; Horst B; Simon K; Twadell W; Lee K; Cohen JA; Wang S; Silvers DN; Brunner G; Celebi JT
Clin Cancer Res; 2009 Jul; 15(13):4288-91. PubMed ID: 19509136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
